FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/29/2023
Back to search
Official data from USPTO
AC AQUACELLE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
03/29/2023
Trademark type
Combined
Nice classes
5
Filing date
04/23/2021
Registration date
11/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2022
Last transaction
11/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
82
Owner location
AU
Examiner
CORNWELL, ANDREA B
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "AC AQUACELLE".
Holders and representatives
Holders
Pharmako Biotechnologies Pty Limited
Representatives
Jennifer A. Visintine Thompson Coburn LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals all in the nature of pharmaceutical preparation for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceuticalcosmeceuticalveterinary applications comprising tabletsgelscreamsoral suspensionirrigation solutionbeveragescapsulespowdered preparationsliquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredientsvitamin Dvitamin Evitamin Avitamin Komega-3s and co-enzyme Q10for the continuous release of a wide variety of therapeutic agents; nutritional preparations for medical usemedications used for the delivery and absorption of nutrients being pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceuticalcosmeceuticalveterinary applications comprising tabletsgelscreamsoral suspensionirrigation solutionbeveragescapsulespowdered preparationsliquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredientsvitamin Dvitamin Evitamin Avitamin Komega-3s and co-enzyme Q10for the continuous release of a wide variety of therapeutic agents; chemical products for use in medical or veterinary biotechnologychemical preparations for increasing bioavailability and absorption of active ingredients in foodstuffs and medicinesbeing pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for comprising tabletsgelscreamsoral suspensionirrigation solutionbeveragescapsulespowdered preparationsliquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredientsvitamin Dvitamin Evitamin Avitamin Komega-3s and co-enzyme Q10for the continuous release of a wide variety of therapeutic agents; medicated food additives being pharmaceutical products that facilitate or increase the absorption of vitamins and mineralspharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceuticalcosmeceuticalveterinary applications comprising tabletsgelscreamsoral suspensionbeveragescapsulespowdered preparationsliquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredientsvitamin Dvitamin Evitamin Avitamin Komega-3s and co-enzyme Q10for the continuous release of a wide variety of therapeutic agents
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/08/2023
FIMP
FINAL DISPOSITION PROCESSED
03/08/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/15/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/15/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/15/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/17/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/30/2022
PUBO
PUBLISHED FOR OPPOSITION
08/30/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/13/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/13/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/08/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/08/2022
RFNT
REFUSAL PROCESSED BY IB
01/30/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/13/2022
RFRR
REFUSAL PROCESSED BY MPU
01/13/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/22/2021
CNRT
NON-FINAL ACTION WRITTEN
12/21/2021
DOCK
ASSIGNED TO EXAMINER
12/17/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/17/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/13/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/01/2021
Continuous trademark protection
Get notified about every new filing that threatens AC AQUACELLE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.